ArticleJournal of clinical medicine2021

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients.

Shane Kaski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.